The FCA issues a warning against DEXONPLATENETRY On October 24, 2024, the Financial Conduct Authority (FCA) issued a warning against DEXONPLATENETRY, believing this company might be providing financial services or products without proper authorization in the UK. https://www.fca.org.uk/news/warnings/dexonplatenetry

BrokersView has reviewed that DEXONPLATENETRY is an unregulated broker Its website displays the certificates of the International Agency for Research on Cancer (IARC) and Company House (CH). As we all know, IARC does not belong to the financial industry and cannot regulate foreign exchange. CH only represents company registration and does not have the right to regulate foreign exchange. To obtain foreign exchange authorization, the Investment Industry Regulatory Organization of Canada (IIROC) and the Financial Conduct Authority (FCA) must be granted permission. After inquiry, no matching information was found in IIROC. We found that the Financial Conduct Authority (FCA) warned against DEXONPLATENETRY, believing this company might be providing financial services or products without proper authorization in the UK.In essence, DEXONPLATENETRY is not regulated by any governing body. Entrusting it with investors' funds is highly risky, as there are no legal protections in place to safeguard the funds.DEXONPLATENETRY appears to be a scam.

BrokersView has identified that Dexonplatenetry's website is currently offline BrokersView found that the domain "https://dexonplatenetry.com/" is currently inaccessible. This is widely regarded as a significant red flag, as the suspension of a broker's website often points to underlying regulatory or operational issues.

Scam site Dexonplatenetry Dear Investor,Thank you for the alert. Dexonplatenetry is indeed a scam.We have listed Dexonplatenetry as a scam broker on our platform for the following reasons:Firstly, Dexonplatenetry uses a certificate allegedly from the IARC to prove its authenticity. However, the IARC, which stands for the International Agency for Research on Cancer, has nothing to do with supervising a financial firm.Secondly, Dexonplatenetry claims to be registered in the UK, but the Financial Conduct Authority (FCA), the major financial regulator in the UK, has issued a warning against Dexonplatenetry, underscoring its unauthorized status.We appreciate your post and your help in our battle against fraudulent brokers. Should you have any further inquiries or need our assistance, do not hesitate to contact us. Our dedicated team is ready to help. View Source